主要收入构成
报告期：2024-12-31
| 主营产品构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 其他（补充） |
1.29% |
34.52 |
17.18% |
30.00 |
13.09% |
-28.61% |
| 其他贸易 |
1.88% |
50.59 |
53.72% |
40.83 |
19.29% |
-0.74% |
| 医药批发 |
21.37% |
574.03 |
32.48% |
541.25 |
5.71% |
-0.95% |
| 医药生产-儿科类 |
30.66% |
823.65 |
-8.60% |
201.58 |
75.53% |
-2.03% |
| 医药生产-妇科类 |
0.70% |
18.86 |
23.83% |
8.32 |
55.90% |
4.54% |
| 医药生产-精神神经类 |
5.84% |
156.86 |
39.35% |
55.72 |
64.48% |
3.48% |
| 医药生产-抗感染类 |
1.41% |
37.87 |
-17.91% |
29.67 |
21.67% |
-20.46% |
| 医药生产-内分泌系统类 |
3.04% |
81.70 |
-17.89% |
24.22 |
70.35% |
-2.17% |
| 医药生产-其他 |
4.47% |
120.04 |
-27.15% |
71.37 |
40.55% |
-10.78% |
| 医药生产-消化系统类 |
3.49% |
93.77 |
19.15% |
18.93 |
79.81% |
7.72% |
| 医药生产-心血管系统 |
19.58% |
525.80 |
-32.13% |
173.00 |
67.10% |
-5.31% |
| 医药生产-原料药类 |
3.57% |
95.90 |
-32.72% |
51.01 |
46.81% |
15.35% |
| 医药生产-止痛类 |
2.70% |
72.45 |
-7.97% |
51.96 |
28.28% |
0.93% |
| 总计 |
2686.04 |
| 行业收入构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 其他（补充） |
1.29% |
34.52 |
17.18% |
30.00 |
13.09% |
-28.61% |
| 其他贸易 |
1.88% |
50.59 |
53.72% |
40.83 |
19.29% |
-0.74% |
| 医药批发 |
21.37% |
574.03 |
32.48% |
541.25 |
5.71% |
-0.95% |
| 医药生产 |
75.46% |
2026.90 |
-16.04% |
685.77 |
66.17% |
-1.59% |
| 总计 |
2686.04 |
| 地区收入构成（百万） |
| 名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
| 出口业务 |
0.31% |
8.23 |
-18.76% |
5.24 |
36.28% |
-3.68% |
| 东北地区 |
6.95% |
186.69 |
-9.33% |
70.07 |
62.47% |
0.67% |
| 华北地区 |
39.16% |
1051.73 |
8.42% |
713.96 |
32.12% |
-5.98% |
| 华东地区 |
17.39% |
467.07 |
-21.30% |
167.82 |
64.07% |
-4.37% |
| 华南地区 |
7.93% |
212.94 |
-1.39% |
45.25 |
78.75% |
-1.12% |
| 华中地区 |
11.15% |
299.42 |
-16.29% |
115.87 |
61.30% |
-5.07% |
| 其他（补充） |
1.29% |
34.52 |
17.18% |
30.00 |
13.09% |
-28.61% |
| 西北地区 |
5.98% |
160.69 |
-17.95% |
72.21 |
55.06% |
0.12% |
| 西南地区 |
9.86% |
264.75 |
-20.08% |
77.42 |
70.76% |
-3.70% |
| 总计 |
2686.04 |
